Redmile Group, LLC - 10%+ Owner at ADC Therapeutics SA

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
ADCT on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Redmile Group, LLC - trading volume in the past year for ADC Therapeutics SA

Holdings reported by Redmile Group, LLC for ADC Therapeutics SA

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Shares, par value CHF 0.08 per share 15,669,217 $44 M $2.81 Jul 1, 2024 Indirect
Pre-Funded Warrants 8,163,265 $39.3 M $4.81 May 8, 2024 Indirect Common Shares
Common Shares, par value CHF 0.08 per share 12,995,040 $36.5 M $2.81 Jul 1, 2024 Direct
Pre-Funded Warrants 6,107,181 $29.4 M $4.81 May 8, 2024 Direct Common Shares
Cash-settled Swaps 107,590 $364 K $3.38 Feb 7, 2024 Direct Common Shares
Cash-settled Swaps 11,159 $37.8 K $3.38 Feb 2, 2024 Indirect Common Shares

Transactions reported by Redmile Group, LLC for ADC Therapeutics SA

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership